HIV :: Adcock Ingram to manufacture ARVs HIV drugs
Adcock Ingram, South Africa?s largest pharmaceutical company, is set to start manufacturing antiretrovirals (ARVs) with immediate effect, following approval by the Medicines Control Council (MCC).
Healthcare
Nanotechnology :: Nanotechnology has potential to generate enormous health benefits
“Nanotechnology has the potential to generate enormous health benefits for the more than five billion people living in the developing world,” according to Dr. Peter A. Singer, senior scientist at the McLaughlin-Rotman Centre for Global Health and Professor of Medicine at University of Toronto.
Tuberculosis :: Opening windows effective way of preventing transmission of TB
A study funded by the Wellcome Trust and the Sir Halley Stewart Trust has shown that opening windows can be more effective than using mechanical ventilation at reducing the risk of transmission of airborne diseases such as tuberculosis (TB).
Diarrhea :: Discovery of chemical profiles for infectious diarrhea
Academics have found, for the first time, smells from healthy feces and people with infectious diarrhea differ significantly in their chemical composition and could be used to diagnose quickly diseases such as Clostridium difficile (C. Diff.).
ADHD :: FDA approves first and only stimulant prodrug VYVANSE as a novel ADHD treatment
Shire plc and its collaborative partner New River Pharmaceuticals Inc., announce the U.S. Food and Drug Administration has granted marketing approval for VYVANSE (lisdexamfetamine dimesylate, formerly known as NRP104), for the treatment of attention deficit hyperactivity disorder. VYVANSE is a prodrug that is therapeutically inactive until metabolized in the body.
NHS :: McConnell opens Stracathro treatment centre
A controversial health centre where NHS patients will be treated by a private company has been opened.
Diabetes :: New storage instructions approved for Byetta
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY) announced that the U.S. Food and Drug Administration (FDA) has approved more convenient patient storage instructions for BYETTA? (exenatide) injection.
HIV :: Safety Alert – Baraclude, entecavir tablets and oral solution
Healthcare professionals are advised that when considering therapy with Baraclude in an HIV/HBV co-infected patient not receiving HAART, the risk of developing HIV resistance cannot be excluded based on current information.
Heart :: MUSC helps turn heart guidelines into lifelines
The Medical University of South Carolina, (MUSC) was recognized for participating in an American Heart Association and American Stroke Association program called Get With the Guidelines.
Heart :: Heart Insight for heart patients, families and caregivers
The American Heart Association and Lippincott Williams & Wilkins, part of Wolters Kluwer Health, announce the launch of a new consumer magazine, Heart Insight, for heart patients, their families and caregivers.